Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Reserve a Booth
Exhibitor Resources
Attend
Housing
Venue
Visa Letter
Exhibit Hall
Program
Schedule
Speakers
Preliminary Guide
Submit an Abstract
MTE #27 Management of Clinically Significant Hypersplenism
Nov
09
2025
Convention Center: Room 158, Level 1
12:45 PM - 1:30 PM
Ticketed Event
World Class Speakers
Discussion Leader
Douglas A. Simonetto, MD
Mayo Clinic Rochester
Discussion Leader
Akash Shukla, MD, DM
Seth GS Medical College & KEM Hospital
Description
In this interactive session, experts focus on the diagnosis of clinically significant hypersplenism, related clinical complications, and management approaches including emerging interventional approaches to clinically important hypersplenism.
Journey Maps
Cirrhosis and Portal Hypertension
Objectives
Explain the approach to diagnosing clinically significant hypersplenism.
Review current management approaches to hypersplenism.
Discuss emerging interventional approaches to manage clinically important hypersplenism.